Sunshield Chemicals is currently trading at Rs. 160.00, up by 6.30 points or 4.10% from its previous closing of Rs. 153.70 on the BSE.
The scrip opened at Rs. 161.35 and has touched a high and low of Rs. 161.35 and Rs. 160.00 respectively. So far 4593 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 173.00 on 16-Jul-2020 and a 52 week low of Rs. 63.00 on 31-Mar-2020.
Last one week high and low of the scrip stood at Rs. 161.35 and Rs. 130.60 respectively. The current market cap of the company is Rs. 118.64 crore.
The promoters holding in the company stood at 62.36%, while Institutions and Non-Institutions held 0.01% and 37.63% respectively.
Sunshield Chemicals has renewed supply contract executed with Elantas GmbH Germany, for a further period of 5 years to supply THEIC product. Based on Current market conditions and potential business recovery in EU and US, the value of Contract could be in the range of Rs 17 crore to Rs 25 crore for a 12 months period.
Sunshield Chemicals is engaged in manufacture and sell of specialty chemicals in domestic and international markets. The Company's principal products include Sun Theic, Alkoxylates, Antioxidant and Miscelleanous.
| Company Name | CMP |
|---|---|
| SRF | 2665.35 |
| BASF India | 3635.10 |
| Tata Chemicals | 729.35 |
| Pidilite Inds. | 1599.75 |
| Deepak Nitrite | 1564.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: